Authors: Deepak Gupta, Rahul Soni
Abstract: Nanoparticles have emerged as a promising tool in the treatment of various eye diseases. Their unique properties, such as small size, large surface area, and the ability to be functionalized, allow for targeted and controlled drug delivery, improved bioavailability, and reduced side effects. This paper reviews the current advancements in nanoparticle-based therapies for eye diseases, including their types, mechanisms of action, and clinical applications. We also discuss the challenges and future prospects of nanoparticle-based ocular treatments.
Keywords: Nanoparticles, Eye diseases, Drug delivery, Glaucoma, Age-related macular degeneration (AMD), Diabetic retinopathy, Ocular infections, Lipid-based nanoparticles, Polymeric nanoparticles, Metal-based nanoparticles, Carbon-based nanoparticles
Full Issue
View or download the full issue | PDF 43-50 |